We provide first-class clinical research
Sanos Group is a Full Circle Clinical Research and Development Organization encompassing six independent business units: NBCD, Sanos Clinic, Sanos Supply, Studies&Me, Blueskin and Omicron.
We are headquartered in Soborg outside Copenhagen, Denmark, where we share the building with NBCD, Blueskin and Omicron.
All business units in the Sanos Group are dedicated to providing first-class clinical research, aiming to keep improving and develop how we conduct innovative clinical trials for our clients and patients. We play a critical role in developing new medication and treatment options, and work diligently to bring new medication faster to the patients.
We are acknowledged for our scientific expertise, and long track record of efficient and innovative clinical trials.
Sanos Group is an organization in rapid development, which means that we rely on our agility and efficiency. At present, Sanos Group consists of around 200 employees, and we are experiencing continuous growth.
September 06, 2024 |
Sanos Group acquires European CRO specializing in Alzheimer's and CNS |
December 20, 2023 |
Sanos Group acquires biostatistics specialist Omicron |
September 01, 2023 |
Asger Kristensen joins the NBCD Management team |
August 07, 2023 |
New paper published in Osteoarthritis and Cartilage Open |
January 18, 2023 |
OARSI Live Webinar on Phenotyping |
September 17, 2024 |
NLSDays |
September 25, 2024 |
EADV Congress |
September 27, 2024 |
SCRS Global |
October 01, 2024 |
OCT Nordics |
October 29, 2024 |
SCOPE Europe |